• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆外泌体作为上皮性卵巢癌的诊断生物标志物。

Plasma exosomal and as diagnostic biomarkers in epithelial ovarian cancer.

机构信息

Post-Doctoral Research Station, Tianjin Medical University, Tianjin.

Department of Gynecological Oncology, Shandong Cancer Hospital & Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, PR China.

出版信息

Future Oncol. 2022 Aug;18(26):2919-2931. doi: 10.2217/fon-2022-0321. Epub 2022 Jul 27.

DOI:10.2217/fon-2022-0321
PMID:35893704
Abstract

The study aimed to clarify the diagnostic value of exosomal miRNAs in epithelial ovarian cancer (EOC). Plasma exosomes were isolated from peripheral blood of EOC patients and healthy donors by ultracentrifugation and verified by transmission electron microscopy, qNano and western blot. The expression of exosomal miRNAs was detected by quantitative PCR, and the diagnostic efficiency of exosomal miRNAs was evaluated by receiver operating characteristic analysis. Exosomal , and were significantly decreased in EOC as compared with healthy controls. The area under the curve of the combination of three exosomal miRNAs was 0.8337. Moreover, the level of exosomal was related to the neutrophil-lymphocyte ratio, which decreased in EOC patients with a high neutrophil-lymphocyte ratio. Exosomal , and act as potentially EOC diagnostic and prognostic biomarkers.

摘要

本研究旨在阐明外泌体 miRNA 在卵巢上皮性癌(EOC)中的诊断价值。通过超速离心从 EOC 患者和健康供体的外周血中分离血浆外泌体,并通过透射电子显微镜、qNano 和 Western blot 进行验证。通过定量 PCR 检测外泌体 miRNA 的表达,并通过接受者操作特征分析评估外泌体 miRNA 的诊断效率。与健康对照组相比,EOC 中外泌体 、 和 明显降低。三种外泌体组合的曲线下面积为 0.8337。此外,外泌体 的水平与中性粒细胞-淋巴细胞比值有关,在中性粒细胞-淋巴细胞比值高的 EOC 患者中降低。外泌体 、 和 可作为潜在的 EOC 诊断和预后生物标志物。

相似文献

1
Plasma exosomal and as diagnostic biomarkers in epithelial ovarian cancer.血浆外泌体作为上皮性卵巢癌的诊断生物标志物。
Future Oncol. 2022 Aug;18(26):2919-2931. doi: 10.2217/fon-2022-0321. Epub 2022 Jul 27.
2
Plasma exosomal miR-320d, miR-4479, and miR-6763-5p as diagnostic biomarkers in epithelial ovarian cancer.血浆外泌体miR-320d、miR-4479和miR-6763-5p作为上皮性卵巢癌的诊断生物标志物
Front Oncol. 2022 Dec 14;12:986343. doi: 10.3389/fonc.2022.986343. eCollection 2022.
3
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer.血浆衍生的外泌体 miR-4732-5p 是一种很有前途的上皮性卵巢癌无创诊断生物标志物。
J Ovarian Res. 2021 Apr 28;14(1):59. doi: 10.1186/s13048-021-00814-z.
4
Diagnostic value of plasma-derived exosomal miR-223 for epithelial ovarian cancer.血浆来源的外泌体miR-223对上皮性卵巢癌的诊断价值
BMC Womens Health. 2024 Mar 2;24(1):150. doi: 10.1186/s12905-024-02976-6.
5
Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.外泌体 miR-99a-5p 在卵巢癌患者血清中升高,并通过增加邻近腹膜间皮细胞中纤连蛋白和 vitronectin 的表达促进癌细胞侵袭。
BMC Cancer. 2018 Nov 5;18(1):1065. doi: 10.1186/s12885-018-4974-5.
6
[Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].血清来源外泌体长链非编码RNA在上皮性卵巢癌诊断价值的初步研究
Zhonghua Fu Chan Ke Za Zhi. 2022 Mar 25;57(3):198-209. doi: 10.3760/cma.j.cn112141-20220114-00022.
7
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.巨噬细胞衍生的外泌体将 miR-223 递送至上皮性卵巢癌细胞以引发耐药表型。
J Exp Clin Cancer Res. 2019 Feb 15;38(1):81. doi: 10.1186/s13046-019-1095-1.
8
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.循环外泌体miR-373、miR-200a、miR-200b和miR-200c在上皮性卵巢癌患者中的诊断和预后相关性
Oncotarget. 2016 Mar 29;7(13):16923-35. doi: 10.18632/oncotarget.7850.
9
Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.血清外泌体 miR-484 低表达预示卵巢癌不良预后。
Cancer Biomark. 2020;27(4):485-491. doi: 10.3233/CBM-191123.
10
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.血清外泌体 microRNA-34a 作为上皮性卵巢癌的一种潜在生物标志物。
J Ovarian Res. 2020 Apr 26;13(1):47. doi: 10.1186/s13048-020-00648-1.

引用本文的文献

1
Exosomal Biomarkers: A Comprehensive Overview of Diagnostic and Prognostic Applications in Malignant and Non-Malignant Disorders.外泌体生物标志物:恶性和非恶性疾病诊断及预后应用的全面概述
Biomolecules. 2025 Apr 15;15(4):587. doi: 10.3390/biom15040587.
2
Molecular mechanisms of miR-192 in cancer: a biomarker and therapeutic target.miR-192在癌症中的分子机制:一种生物标志物和治疗靶点
Cancer Cell Int. 2025 Mar 14;25(1):94. doi: 10.1186/s12935-025-03666-5.
3
Global research trends in liquid biopsy for ovarian cancer from 1999 to 2023: A 25-year bibliometric analysis.
1999年至2023年卵巢癌液体活检的全球研究趋势:一项25年的文献计量分析。
J Liq Biopsy. 2024 May 24;5:100158. doi: 10.1016/j.jlb.2024.100158. eCollection 2024 Sep.
4
Serum-derived exosomal miR-7977 combined with miR-451a as a potential biomarker for pancreatic ductal adenocarcinoma.血清来源的外泌体miR-7977与miR-451a联合作为胰腺导管腺癌的潜在生物标志物。
BMC Cancer. 2025 Feb 19;25(1):295. doi: 10.1186/s12885-025-13659-2.
5
Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis.循环微小RNA作为检测卵巢癌特定阶段的诊断生物标志物:一项综合荟萃分析。
Cancers (Basel). 2024 Dec 16;16(24):4190. doi: 10.3390/cancers16244190.
6
The role of extracellular vesicles in the pathogenesis of gynecological cancer.细胞外囊泡在妇科癌症发病机制中的作用。
Front Oncol. 2024 Sep 26;14:1477610. doi: 10.3389/fonc.2024.1477610. eCollection 2024.
7
Exosomes in diagnostic and therapeutic applications of ovarian cancer.外泌体在卵巢癌诊断和治疗中的应用。
J Ovarian Res. 2024 May 25;17(1):113. doi: 10.1186/s13048-024-01417-0.
8
Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers.妇科癌症中的外泌体非编码RNA:对治疗耐药性和生物标志物的影响
Front Oncol. 2024 Apr 26;14:1349474. doi: 10.3389/fonc.2024.1349474. eCollection 2024.
9
Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer.腹腔液来源的小细胞外囊泡的蛋白质组学特征与卵巢癌患者的预后相关。
J Clin Invest. 2024 Apr 2;134(10):e176161. doi: 10.1172/JCI176161.
10
Construction of an exosome-associated miRNA-mRNA regulatory network and validation of and miR-17-5p as potential biomarkers associated with ovarian cancer.构建外泌体相关的miRNA-mRNA调控网络并验证miR-17-5p作为与卵巢癌相关的潜在生物标志物。
Transl Cancer Res. 2024 Feb 29;13(2):1052-1067. doi: 10.21037/tcr-23-940. Epub 2024 Feb 28.